Hartland & Co »

Lexicon Pharmaceuticals shares owned by Hartland & Co

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $240 100 2.40

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Paccar (PCAR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Amazon Call Call Option (AMZN)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Call Call Option (VTI)

View all positions for Hartland & Co

Top funds holding Lexicon Pharmaceuticals

Artal Group
FMR
Siren
Sessa Capital IM
BlackRock
Vanguard Capital Management
Point72 Asset Management
Geode Capital Management
Vanguard Portfolio Management
Citadel Advisors
Northern Trust
Charles Schwab Investment Management
Sixth Street Partners Management Company
Vanguard Fiduciary Trust
Susquehanna International

View all funds holding Lexicon Pharmaceuticals